help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2008-0972
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Google Scholar
Right arrow Articles by Chesnokova, V.
Right arrow Articles by Yu, R.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chesnokova, V.
Right arrow Articles by Yu, R.
Endocrinology Vol. 150, No. 6 2603-2610
Copyright © 2009 by The Endocrine Society

Diminished Pancreatic β-Cell Mass in Securin-Null Mice Is Caused by β-Cell Apoptosis and Senescence

Vera Chesnokova, Chris Wong, Svetlana Zonis, Anna Gruszka, Kolja Wawrowsky, Song-Guang Ren, Anat BenShlomo and Run Yu

Division of Endocrinology, Diabetes, and Metabolism, Cedars-Sinai Medical Center, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California 90048

Address all correspondence and requests for reprints to: Run Yu, M.D., Ph.D., Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Room D3066, Los Angeles, California 90048. E-mail: run.yu{at}cshs.org.

Pituitary tumor transforming gene (PTTG) encodes a securin protein critical in regulating chromosome separation. PTTG-null (PTTG–/–) mice exhibit pancreatic β-cell hypoplasia and insulinopenic diabetes. We tested whether PTTG deletion causes β-cell senescence, resulting in diminished β-cell mass. We examined β-cell mass, proliferation, apoptosis, neogenesis, cell size, and senescence in PTTG–/– and WT mice from embryo to young adulthood before diabetes is evident. The roles of cyclin-dependent kinase inhibitors and DNA damage in the pathogenesis of diabetes in PTTG–/– mice were also addressed. Relative β-cell mass in PTTG–/– mice began to decrease at 2–3 wk, whereas β-cell proliferation rate was initially normal but decreased in PTTG–/– mice beginning at 2 months. Apoptosis was also much more evident in PTTG–/– mice. At 1 month, β-cell neogenesis was robust in wild-type mice but was absent in PTTG–/– mice. In addition, the size of β-cells became larger and macronuclei were prominent in PTTG–/– animals. Senescence-associated β-galactosidase was also active in PTTG–/– β-cells at 1 month. Cyclin-dependent kinase inhibitor p21 was progressively up-regulated in PTTG–/– islets, and p21 deletion partially rescued PTTG–/– mice from development of diabetes. mRNA array showed that DNA damage-associated genes were activated in PTTG–/– islets. We conclude that β-cell apoptosis and senescence contribute to the diminished β-cell mass in PTTG–/– mice, likely secondary to DNA damage. Our results also suggest that ductal progenitor β-cells are exhausted by excessive neogenesis induced by apoptosis in PTTG–/– mice.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2009 by The Endocrine Society